World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. – ALNY

Cision PR Newswire by Cision PR Newswire
November 19, 2026
in Press Releases
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

NEW YORK, Nov. 19, 2026 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc. (“Alnylam” or the “Company”) (NASDAQ: ALNY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years

The investigation concerns whether Alnylam and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On October 29, 2026, Alnylam reported its financial results for the third quarter ended September 30, 2026.  Among other items, the Company reported slowing demand for one of its transthyretin-mediated amyloidosis treatments, Amvuttra, which accounts for 87.5% of Alnylam’s product sales.  Alnylam announced U.S. total transthyretin demand growth of $81 million, compared to $129 million for the preceding quarter. 

On this news, Alnylam’s stock price fell $58.40, or 25.13%, to close at $174.00 on October 29, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-alnylam-pharmaceuticals-inc—alny-302945306.html

SOURCE Pomerantz LLP

Cision PR Newswire

Cision PR Newswire

Related Posts

Republic Business Credit Promotes Brian Daray to EVP, Head of Credit and Jerry Friedrichs to SVP, Underwriting Manager

November 19, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VinFast Auto Ltd. – VFS

November 19, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LKQ Corporation – LKQ

November 19, 2026

FLX Networks Members Begin Sharing Pre-IPO Private Market Opportunities with Advisors

November 19, 2026

IRG Signs Long-Term Lease with Chick-fil-A at Titan Center in Pocatello

November 19, 2026

Kennedy Funding Closes $1.1 Million Loan for Church and Daycare Facility in Bowie, Maryland

November 19, 2026

Popular News

  • Republic Business Credit Promotes Brian Daray to EVP, Head of Credit and Jerry Friedrichs to SVP, Underwriting Manager

    0 shares
    Share 0 Tweet 0
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VinFast Auto Ltd. – VFS

    0 shares
    Share 0 Tweet 0
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LKQ Corporation – LKQ

    0 shares
    Share 0 Tweet 0
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. – ALNY

    0 shares
    Share 0 Tweet 0
  • IRG Signs Long-Term Lease with Chick-fil-A at Titan Center in Pocatello

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler